SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review

SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review

Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and to analyse the sex-related beneficial and adverse effects. The histone deacetylase inhibitor valproic acid (VPA)...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Donatas Stakišaitis, Linas Kapočius, Angelija Valančiūtė, Ingrida Balnytė, Tomas Tamošuitis, Arūnas Vaitkevičius, Kęstutis Sužiedėlis, Daiva Urbonienė, Vacis Tatarūnas, Evelina Kilimaitė, Dovydas Gečys, Vaiva Lesauskaitė
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2022-04-01
Schriftenreihe:Biomedicines
Schlagworte:
valproic acid
COVID-19
sex differences
pre-clinical research
clinical research
Online Zugang:https://www.mdpi.com/2227-9059/10/5/962

Online

https://www.mdpi.com/2227-9059/10/5/962

Ähnliche Einträge